Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
$1.14B |
| 2 |
AbbVie
ABBV
|
$537M |
| 3 |
T-Mobile US
TMUS
|
$504M |
| 4 |
Baidu
BIDU
|
$474M |
| 5 |
Kroger
KR
|
$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
$1.26B |
| 3 |
S
Sprint Corporation
S
|
$675M |
| 4 |
Nabors Industries
NBR
|
$638M |
| 5 |
Amgen
AMGN
|
$504M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$140B
| $685M | 0.59% |
8,901,247
-3,629,962
| -29% | -$279M |
|
27
Molina Healthcare
MOH
$9.92B
| $654M | 0.56% |
3,676,459
-471,650
| -11% | -$83.9M |
|
28
Incyte
INCY
$17B
| $652M | 0.56% |
6,271,350
+1,669,090
| +36% | +$174M |
|
29
Hershey
HSY
$37.6B
| $651M | 0.56% |
5,025,538
-229,600
| -4% | -$29.8M |
|
30
Vodafone
VOD
$28.1B
| $610M | 0.53% |
38,243,408
+2,100,500
| +6% | +$33.5M |
|
31
Align Technology
ALGN
$9.94B
| $607M | 0.52% |
2,210,548
-727,681
| -25% | -$200M |
|
|
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $573M | 0.49% |
10,312,875
-310,800
| -3% | -$17.3M |
|
33
Domino's
DPZ
$15.9B
| $569M | 0.49% |
1,539,725
-441,800
| -22% | -$163M |
|
34
Regeneron Pharmaceuticals
REGN
$62.2B
| $555M | 0.48% |
890,100
+402,738
| +83% | +$251M |
|
35
Exelixis
EXEL
$10.1B
| $546M | 0.47% |
23,006,910
+2,935,850
| +15% | +$69.7M |
|
|
ABMD
36
DELISTED
Abiomed Inc
ABMD
| $544M | 0.47% |
2,250,122
+202,122
| +10% | +$48.8M |
|
37
Cable One
CABO
$896M
| $543M | 0.47% |
305,900
-6,200
| -2% | -$11M |
|
|
38
T-Mobile US
TMUS
$284B
| $539M | 0.47% |
5,175,106
+4,837,921
| +1,435% | +$504M |
|
39
NetEase
NTES
$86B
| $533M | 0.46% |
1,242,136
+300,236
| +32% | +$129M |
|
40
MarketAxess Holdings
MKTX
$6.71B
| $519M | 0.45% |
1,035,564
-165,800
| -14% | -$83.1M |
|
|
ALXN
41
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $503M | 0.43% |
4,479,243
+715,741
| +19% | +$80.3M |
|
42
Herbalife
HLF
$1.01B
| $495M | 0.43% |
10,997,964
+1,315,061
| +14% | +$59.2M |
|
43
Dropbox
DBX
$7.74B
| $484M | 0.42% |
22,225,426
+3,028,900
| +16% | +$65.9M |
|
44
DexCom
DXCM
$29.6B
| $480M | 0.41% |
1,183,076
+233,747
| +25% | +$94.8M |
|
45
Petrobras
PBR
$80.1B
| $474M | 0.41% |
57,313,130
-8,857,200
| -13% | -$73.2M |
|
46
Etsy
ETSY
$5.16B
| $474M | 0.41% |
4,461,161
+212,100
| +5% | +$22.5M |
|
47
United Therapeutics
UTHR
$18.5B
| $451M | 0.39% |
3,726,818
+136,595
| +4% | +$16.5M |
|
48
Teradyne
TER
$19.4B
| $447M | 0.39% |
5,284,649
-556,701
| -10% | -$47M |
|
49
F5
FFIV
$17.6B
| $438M | 0.38% |
3,136,774
+417,700
| +15% | +$58.3M |
|
50
Icon
ICLR
$14.2B
| $433M | 0.37% |
2,568,719
+67,400
| +3% | +$11.4M |
|